Skip to main content

Table 1 Baseline characeteristics of study patients

From: A randomized, placebo-controlled trial to determine the course of aminotransferase elevation during prolonged acetaminophen administration

  Placebo (n = 47) Acetaminophen (n = 205)
Age (years) 32 (19.0, 64.0) 34 (18.0 to 74.0)
Male 12 (25.5%) 57 (27.8%)
Race   
White 35 (74.5%) 142 (69.3%)
 Hispanic 4 (8.5%) 33 (16.1%)
 Black 4 (8.5%) 13 (6.3%)
 Other/Mixed 4 (8.5%) 17 (8.3%)
Body Mass Index 23.8 (17.3, 48.8) 25.8 (16.5, 53.5)
Self-reported ethanol use 35 (74.5%) 167 (81.5%)
Baseline ALT 17.0 (11.0, 47.0) 19.0(9.0, 44.0)
  1. Note: median (range) were provided for Age, BMI and Baseline ALT.